Display options
Cite
Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55-66doi: 10.2147/TACG.S58444.
Buchbinder, D., Nugent, D. J., & Fillipovich, A. H. (2014). Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. The application of clinical genetics, 755-66. https://doi.org/10.2147/TACG.S58444
Buchbinder, David, et al. "Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments." The application of clinical genetics vol. 7 (2014): 55-66. doi: https://doi.org/10.2147/TACG.S58444
Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014 Apr 03;7:55-66. doi: 10.2147/TACG.S58444. eCollection 2014. PMID: 24817816; PMCID: PMC4012343.
Copy Download .nbib Format: NLM
Share it on

Appl Clin Genet. 2014 Apr 03;7:55-66. doi: 10.2147/TACG.S58444. eCollection 2014.

Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments.

The application of clinical genetics

David Buchbinder, Diane J Nugent, Alexandra H Fillipovich

Affiliations

  1. Division of Hematology, Children's Hospital of Orange County, Orange, CA, USA.
  2. Division of Immunology, Cincinnati Children's Hospital, Cincinnati, OH, USA.

PMID: 24817816 PMCID: PMC4012343 DOI: 10.2147/TACG.S58444

Abstract

Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency disorder characterized by the triad of eczema, thrombocytopenia, and severe and often recurrent infections. Despite the rarity of this disorder, our understanding of the molecular and cellular pathogenesis of WAS has continued to increase. Advances in the use of diagnostic tools, the provision of supportive care, and improvements in allogeneic hematopoietic stem cell transplantation have significantly reduced the morbidity and mortality associated with this disorder. Exciting advancements in the care of patients with WAS have also occurred, including the successful application of autologous gene-modified hematopoietic stem cell transplantation.

Keywords: Wiskott–Aldrich syndrome; gene therapy; hematopoietic stem cell transplantation; primary immunodeficiency

References

  1. J Pediatr. 1994 Dec;125(6 Pt 1):876-85 - PubMed
  2. Blood. 1999 Dec 1;94(11):3872-82 - PubMed
  3. Immunol Res. 2011 Oct;51(1):61-70 - PubMed
  4. J Pediatr Hematol Oncol. 2013 Aug;35(6):e234-8 - PubMed
  5. Blood. 2013 Feb 28;121(9):1484-5 - PubMed
  6. Science. 2013 Aug 23;341(6148):1233151 - PubMed
  7. Immunol Res. 2009;44(1-3):18-24 - PubMed
  8. Bone Marrow Transplant. 2006 Nov;38(10):671-9 - PubMed
  9. Blood. 2004 Jan 15;103(2):456-64 - PubMed
  10. Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):427-36 - PubMed
  11. Ann N Y Acad Sci. 2013 May;1285:26-43 - PubMed
  12. Br J Haematol. 2007 Oct;139(1):98-105 - PubMed
  13. J Natl Cancer Inst Monogr. 2005;(34):87-90 - PubMed
  14. Arch Dis Child. 1996 Nov;75(5):436-9 - PubMed
  15. Br J Haematol. 2010 Feb;148(3):416-27 - PubMed
  16. Haematologica. 2011 Oct;96(10):1415-23 - PubMed
  17. Exp Hematol. 2009 Nov;37(11):1353-63 - PubMed
  18. Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11351-6 - PubMed
  19. Pediatr Infect Dis J. 1988 May;7(5 Suppl):S10-2 - PubMed
  20. Pediatr Blood Cancer. 2013 May;60(5):836-41 - PubMed
  21. J Clin Immunol. 2011 Oct;31(5):773-7 - PubMed
  22. Blood. 2002 Aug 15;100(4):1208-14 - PubMed
  23. Blood. 2013 Feb 28;121(9):1510-6 - PubMed
  24. Prenat Diagn. 2003 Dec 15;23(12):1014-6 - PubMed
  25. Pediatr Hematol Oncol. 2007 Sep;24(6):393-402 - PubMed
  26. Br J Haematol. 2011 Aug;154(3):363-72 - PubMed
  27. Pediatr Allergy Immunol. 1995 May;6(2):91-4 - PubMed
  28. J Immunol Methods. 2002 Feb 1;260(1-2):195-205 - PubMed
  29. Blood. 2010 Apr 22;115(16):3231-8 - PubMed
  30. J Allergy Clin Immunol. 2011 Apr;127(4):998-1005.e1-2 - PubMed
  31. J Immunol. 2000 Jul 15;165(2):1119-22 - PubMed
  32. Blood. 1997 Oct 1;90(7):2680-9 - PubMed
  33. Reprod Biomed Online. 2004 Aug;9(2):210-21 - PubMed
  34. J Clin Immunol. 2013 Oct;33(7):1150-5 - PubMed
  35. Bone Marrow Transplant. 2012 Nov;47(11):1428-35 - PubMed
  36. Blood. 2011 Aug 11;118(6):1675-84 - PubMed
  37. Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S53-S56 - PubMed
  38. Blood. 2011 Apr 21;117(16):4367-75 - PubMed
  39. Lancet. 2003 Feb 15;361(9357):553-60 - PubMed
  40. Blood. 2001 Mar 15;97(6):1598-603 - PubMed
  41. Bone Marrow Transplant. 2007 Oct;40(7):633-42 - PubMed
  42. Cancer Invest. 1985;3(6):515-22 - PubMed
  43. J Cell Sci. 2012 Jun 15;125(Pt 12):2825-30 - PubMed
  44. Br J Haematol. 2006 Nov;135(3):362-6 - PubMed
  45. J Clin Invest. 2007 Feb;117(2):407-18 - PubMed
  46. Blood. 2012 Mar 22;119(12):2819-28 - PubMed
  47. Biol Blood Marrow Transplant. 2013 Mar;19(3):338-43 - PubMed
  48. Biol Blood Marrow Transplant. 2011 Dec;17(12):1783-9 - PubMed
  49. Lancet. 2014 Feb 1;383(9915):436-48 - PubMed
  50. Blood. 2012 Oct 25;120(17):3563-74 - PubMed
  51. J Exp Med. 1999 Nov 1;190(9):1329-42 - PubMed
  52. Immunol Res. 2009;44(1-3):127-31 - PubMed
  53. J Allergy Clin Immunol. 2010 Sep;126(3):602-10.e1-11 - PubMed
  54. Gene. 2013 Aug 10;525(2):170-3 - PubMed
  55. Blood. 2008 Jan 1;111(1):439-45 - PubMed
  56. N Engl J Med. 2010 Nov 11;363(20):1918-27 - PubMed

Publication Types